Reduction of Cytotoxicity of the Alkaloid Emetine through P-Glycoprotein (MDR1/ABCB1) in Human Caco-2 Cells and Leukemia Cell Lines

Abstract

The cytotoxicity of the alkaloid emetine was determined in six human cell lines that differ in the expression of ABC transporters, such as multiple drug resistance protein 1 (MDR1/ABCB1) and multidrug resistance associated protein 1 (MRP1/ABCC1). Emetine reveals a substantial cytotoxicity due to apoptosis that is inversely correlated with the expression of MDR1. Confluent Caco-2 cells with high MDR1 activity and the MDR1 over-expressing leukemia cell line CEM/ADR5000 are more resistant towards emetine (EC₅₀ 250 μM and 2 μM, respectively) than cells with a low expression of MDR1 (Jurkat cells, CCRF-CEM cells, HL-60 cells) or cells which over-express MRP1 (HL-60/AR) (EC₅₀ between 0.05 μM for CCRF-CEM and 0.17 μM for Jurkat cells). Apparently emetine is a substrate for MDR1 but not for MRP1. Furthermore, emetine is able to up-regulate the expression of MDR1 as shown in vitro by real-time PCR and transport activity studies.

Emetine - cytotoxicity - ABC-transporter - P-glycoprotein - MDR1 - MRP1

References

• 1 Wyk B -Ev, Wink M. Medicinal plants of the world. Pretoria; Briza 2004
• 2 Bell D R. Treatment of amoebiasis.  Trop Doct. 1973;  3 140-3
• 3 Grollman A P. Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between Ipecac alkaloids and glutarimide antibiotics.  Proc Natl Acad Sci USA. 1966;  56 1867-74
• 4 Gupta R S, Siminovitch L. The isolation and preliminary characterization of somatic cell mutants resistant to the protein synthesis inhibitor-emetine.  Cell. 1976;  9 213-9
• 5 Grollman A P, Huang M T. Inhibitors of protein synthesis in eukaryotes: tools in cell research.  Fed Proc. 1673;  32 1673-8
• 6 Pestka S. Inhibitors of ribosome functions.  Annu Rev Microbiol. 1971;  25 487-562
• 7 Watanabe N, Shimada H. Effects of emetine on initiation of DNA synthesis in embryonic cells of sea urchin.  Cell Differ. 1983;  13 239-45
• 8 Wink M, Schmeller T, Latz-Brüning B. Modes of action of allelochemical alkaloids: interaction with neuroreceptors, DNA, and other molecular targets.  J Chem Ecol. 1998;  24 1881-937
• 9 Wink M. Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective.  Phytochemistry. 2003;  64 3-19
• 10 Stuffness M, Douros J D. Miscellaneous natural products with antitumor activity. In: Cassady JM, Douros JD, editors Anticancer agents based on natural product models. New York; Academic Press 1980: p 469-70
• 11 Kochi S K, Collier R J. DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis.  Exp Cell Res. 1993;  208 296-302
• 12 Bicknell G R, Snowden R T, Cohen G M. Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937.  J Cell Sci. 1994;  107 2483-9
• 13 Watanabe N, Iwamoto T, Dickinson D A, Iles K E, Forman H J. Activation of the mitochondrial caspase cascade in the absence of protein synthesis does not require c-Jun N-terminal kinase.  Arch Biochem Biophys. 2002;  405 231-40
• 14 Samuelson J, Ayala P, Orozco E, Wirth D. Emetine-resistant mutants of Entamoeba histolytica overexpress mRNAs for multidrug resistance.  Mol Biochem Parasitol. 1990;  38 281-90
• 15 Borgnia M J, Eytan G D, Assaraf Y G. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.  J Biol Chem. 1996;  271 3163-71
• 16 Wang E, Lew K, Barecki M, Casciano C N, Clement R P, Johnson W W. Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4.  Chem Res Toxicol. 2001;  14 1596-603
• 17 Gant T W, Silverman J A, Thorgeirsson S S. Regulation of P-glycoprotein gene expression in hepatocyte cultures and liver cell lines by a trans-acting transcriptional repressor.  Nucleic Acids Res. 1992;  20 2841-6
• 18 Borenfreund E, Babich H, Martin-Alguacil N. Rapid chemosensitivity assay with human normal and tumor cells in vitro .  In Vitro Cell Dev Biol. 1990;  26 1030-4
• 19 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.  J Immunol Methods. 1983;  65 55-63
• 20 Nicoletti I, Migliorati G, Pagliacci M C, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.  J Immunol Methods. 1991;  139 271-9
• 21 Ludescher C, Thaler J, Drach D, Drach J, Spitaler M, Gattringer C. et al . Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.  Br J Haematol. 1992;  82 161-8
• 22 Albermann N, Schmitz-Winnenthal F H, Z'graggen K, Volk C, Hoffmann M M, Haefeli W E. et al . Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.  Biochem Pharmacol. 2005;  70 949-58
• 23 Lin H -L, Liu T -Y, Chi C -W, Wu C -W. Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel.  Br J Cancer. 1999;  81 416-22
• 24 Tebbi C K, Chervinsky D, Baker R M. Modulation of drug resistance in homoharringtonine-resistant C-1300 neuroblastoma cells with cyclosporine A and dipyridamole.  J Cell Physiol. 1991;  148 464-71
• 25 Hoskins J, DeHerdt S V, Moore R E, Bumol T F. The development and characterization of Vinca alkaloid-resistant Caco-2 human colorectal cell lines expressing mdr-1.  Int J Cancer. 1993;  53 680-8
• 26 Michieli M, Damiani D, Geromin A, Michelutti A, Fanin R, Raspadori D. et al . Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia.  Eur J Haematol. 1992;  48 87-92
• 27 Fricker G, Drewe J, Huwyler J, Gutmann H, Beglinger C. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation.  Br J Pharmacol. 1996;  118 1841-7